Načítá se...
The effect of Oncotype DX(®) on adjuvant chemotherapy treatment decisions in early breast cancer
INTRODUCTION: The aim of this study was to objectively establish the value of the Oncotype DX(®) (ODX) gene assay in adjuvant treatment decisions for intermediate risk patients with early, oestrogen receptor positive, human epidermal growth factor receptor 2 negative, lymph node negative breast canc...
Uloženo v:
| Vydáno v: | Ann R Coll Surg Engl |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Royal College of Surgeons
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6818070/ https://ncbi.nlm.nih.gov/pubmed/31219316 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1308/rcsann.2019.0096 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|